|
|
|
|
|
|
Association of anemia and renal function test among diabetes mellitus patients attending Fenote Selam Hospital, West Gojam, Northwest Ethiopia: a cross sectional study
Alemayehu Abate, Wubet Birhan, Abebe Alemu BMC Hematology 2013, 13:6 (7 May 2013)
Abstract | Provisional PDF
|
|
|
|
Local concepts of anemia-related illnesses and public health implications in the Taabo health demographic surveillance system, Côte d’Ivoire
M’Bra KD Kouadio, Aurélie A Righetti, Noël N Abé, Rita Wegmüller, Mitchell G Weiss, Eliézer K N’Goran, Jürg Utzinger BMC Hematology 2013, 13:5 (6 May 2013)
Abstract | Full text | PDF
|
|
|
|
Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab?
Trine H Mogensen, Jens Magnus Bernth-Jensen, Charlotte C Petersen, Mikkel S Petersen, Charlotte Nyvold, Karsten H Gadegaard, Marianne Hokland, Peter Hokland, Carsten S Larsen BMC Hematology 2013, 13:4 (11 April 2013)
Abstract | Provisional PDF
|
|
|
|
Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients
Basim Mohammad Ayesh, Wael Mohammad Harb, Abdalla Assaf Abed BMC Hematology 2013, 13:3 (10 April 2013)
Abstract | Full text | PDF
| ePUB
|
|
|
|
An interview with Dan L. Longo, Section Editor of the Malignant hematological diseases section
Dan L Longo BMC Hematology 2013, 13:2 (10 April 2013)
Abstract | Full text | PDF
| ePUB
|
Editor’s summary
Section Editor Dan L Longo relates how he first became interested in hematology and gives his personal view on the recent progress and future challenges of the hematological cancer field in particular.
|
|
|
|
BMC Blood Disorders becomes BMC Hematology: evolving along with the hematology field
Christna Chap BMC Hematology 2013, 13:1 (10 April 2013)
Abstract | Full text | PDF
| ePUB
|
Editor’s summary
This Editorial discusses the rationale behind the launch of BMC Hematology, formerly known as BMC Blood Disorders, within the BMC series of journals published by BioMed Central.
|
|
|
|
Foetal haemoglobin and disease severity in sickle cell anaemia patients in Kampala, Uganda
Lena Mpalampa, Christopher M Ndugwa, Henry Ddungu, Richard Idro BMC Blood Disorders 2012, 12:11 (7 September 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases
Matthieu Resche-Rigon, Romain Pirracchio, Marie Robin, Regis De Latour, David Sibon, Lionel Ades, Patricia Ribaud, Jean-Paul Fermand, Catherine Thieblemont, Gérard Socié, Sylvie Chevret BMC Blood Disorders 2012, 12:10 (16 August 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation
Mary Fuchs, Mike Reinhöfer, Andreas Ragoschke-Schumm, Herbert G Sayer, Klas Böer, Otto W Witte, Andreas Hochhaus, Hubertus Axer BMC Blood Disorders 2012, 12:9 (7 August 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Syncytial giant cell hepatitis associated with chronic lymphocytic leukemia: a case report
Eva Gupta, Michael Yacoub, Martha Higgins, Ayad M Al-Katib BMC Blood Disorders 2012, 12:8 (19 July 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Prevalence and type of monoclonal gammopathy of undetermined significance in an apparently healthy Nigerian population: a cross sectional study
A Onwah, Titilope A Adeyemo, Adewumi Adediran, Sarah O Ajibola, Alani S Akanmu BMC Blood Disorders 2012, 12:7 (28 June 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Health related quality of life in Middle Eastern children with beta-thalassemia
Giovanni Caocci, Fabio Efficace, Francesca Ciotti, Maria Roncarolo, Adriana Vacca, Eugenia Piras, Roberto Littera, Raji Suleiman Markous, Gary Collins, Fabio Ciceri, Franco Mandelli, Sarah Marktel, Giorgio La Nasa BMC Blood Disorders 2012, 12:6 (22 June 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Zinc finger nucleases for targeted mutagenesis and repair of the sickle-cell disease mutation: An in-silico study
Misaki Wayengera BMC Blood Disorders 2012, 12:5 (14 May 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Molecular characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city - Iraq
Bassam MS Al-Musawi, Nasir Al-Allawi, Ban A Abdul-Majeed, Adil A Eissa, Jaladet MS Jubrael, Hanan Hamamy BMC Blood Disorders 2012, 12:4 (27 March 2012)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is highly prevalent among the Arab population of central Iraq with the Mediterranean, Chatham and A- polymorphic variants constituting more than 80% of deficient variants.
|
|
|
|
Hemoglobin E syndromes in Pakistani population
Bushra Moiz, Mashhooda Hashmi, Amna Nasir, Anila Rashid, Tariq Moatter BMC Blood Disorders 2012, 12:3 (25 March 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Patient-reported treatment burden of chronic immune thrombocytopenia therapies
T Brown, Ruslan V Horblyuk, Kelly M Grotzinger, Axel C Matzdorff, Chris L Pashos BMC Blood Disorders 2012, 12:2 (22 March 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Fanconi anaemia with bilateral diffuse pulmonary arterio venous fistulae: a case report
Lasitha Samarakoon, Nuwan Ranawaka, Chaturaka Rodrigo, Godwin R Constantine, Lalindra Goonarathne BMC Blood Disorders 2012, 12:1 (17 March 2012)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial data
R Andrew Moore, Helen Gaskell, Peter Rose, Jonathan Allan BMC Blood Disorders 2011, 11:4 (24 September 2011)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Evidence from the literature suggests that, in line with current recommendations, intravenous ferric carboxymaltose is effective and safe in treating iron deficiency anemia in many chronic conditions, but there are limited trial data comparing different intravenous iron preparations.
|
|
|
|
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review
Neelam Giri, Rees Lee, Albert Faro, Charles B Huddleston, Frances V White, Blanche P Alter, Sharon A Savage BMC Blood Disorders 2011, 11:3 (15 June 2011)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Serum levels of leptin in Nigerian patients with sickle cell anaemia
Bamidele A Iwalokun, Senapon O Iwalokun, Semande O Hodonu, Ayoola O Aina, Phillip U Agomo BMC Blood Disorders 2011, 11:2 (26 May 2011)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Plasma concentrations of leptin are further decreased in the unsteady state of sickle cell anaemia (HbSS) and positively correlate with inflammation and poor reticulocyte response, but not with adiposity and malarial infection
|
|
|
|
Erythrocyte reference values in Emirati people with and without α+ thalassemia
Srdjan Denic, Abdul-Kader Souid, Nicolaas Nagelkerke, Saad Showqi, Ghazala Balhaj BMC Blood Disorders 2011, 11:1 (24 February 2011)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Erythrocyte reference values for normal and alpha+ thalassemia homozygotes can be determined by analyzing the erythroid lineage of populations with frequent alpha+ thalassemia mutations, and these values are similar to those found by genotyping and other phenotyping methods.
|
|
|
|
Pica associated with iron deficiency or depletion: clinical and laboratory correlates in 262 non-pregnant adult outpatients
James C Barton, J Clayborn Barton, Luigi F Bertoli BMC Blood Disorders 2010, 10:9 (22 December 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor
Gyan K Kayastha, Padma Gurung, Paras K Acharya, Buddhi P Paudyal, Bruce Hayes, Mark Zimmerman, Arjun Karki, Aaron S Mansfield BMC Blood Disorders 2010, 10:8 (7 December 2010)
Abstract | Full text | PDF
| PubMed
|
Editor’s summary
Patients with Philadelphia chromosome/ BCR-ABL1 positive chronic myeloid leukaemia (CML) can be effectively treated with Gleevec (imatinib mesylate), a selective inhibitor of tyrosine kinase, but further cytogenetic analyses are needed to detect inadequate responses and adjust therapy.
|
|
|
|
Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission
Mariana Serpa, Sabri S Sanabani, Pedro Dorliac-Llacer, Monika Conchon, Thales Pereira, Luciana Nardinelli, Juliana Costa, Mafalda Novaes, Patricia Ferreira, Israel Bendit BMC Blood Disorders 2010, 10:7 (18 November 2010)
Abstract | Full text | PDF
| PubMed
|
|
|
|
Prevalence and molecular characterization of Glucose-6-Phosphate dehydrogenase deficient variants among the Kurdish population of Northern Iraq
Nasir Al-Allawi, Adil A Eissa, Jaladet MS Jubrael, Shakir AR Jamal, Hanan Hamamy BMC Blood Disorders 2010, 10:6 (5 July 2010)
Abstract | Full text | PDF
| PubMed | Cited on BioMed Central
|
Editor’s summary
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is highly prevalent among the Kurdish population of Northern Iraq, with most cases being due to the G6PD Mediterranean and Chatham variants.
|